Transform research and care with everyday health insights
Technology, experience design, and two-way communication that fosters long term data sharing and enables quick activation of individuals towards care and research.
retention for 4-month uterine fibroid pain study
greater precision in identifying individuals exhibiting flu-like symptoms with predictive algorithm compared to blanket advertising
Expertise in using machine learning to better characterize diseases and identify health risks.
High risk COPD exacerbations identified 2 weeks prior to typical hospitalization times
COVID-19 incidence rate in a decentralized trial than was observed in vaccine trials using precision recruitment compared to traditional methods
Our community is one of the largest virtually connected digital health cohorts in the United States that regularly contributes their data and time to groundbreaking research.
Evidation experiences are designed with individuals at the center, and feature a user-permissioned approach to data sharing that ensures people have control over their data.
Type 2 diabetes flu vaccine education program enabled life sciences company to test and refine content and messaging over time.
increased flu vaccination rates* for participants who engaged with customized diabetes content.
Evidence-based learnings to scale to broader vaccination programs
*Based on self-reported vaccination status
Met complex inclusion and exclusion criteria related to chronic migraine episode frequency and other key characteristics
of first 15,000 participants downloaded personalized insights report
of individuals who shared their report with their care team found it helpful or extremely helpful
Study aims to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.
Data sources integrated include Medicare claims, HealthKit app data, and ePRO data.
Evidation partners include nine of the top 10 biopharma companies in the world, as well as insurers, health systems, technology companies, academia, professional societies, and government agencies.